ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is ResMed, Inc. ?
1
High Management Efficiency with a high ROCE of 25.79%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.50 times
3
Healthy long term growth as Operating profit has grown by an annual rate 15.84%
4
The company has declared Positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 1,751.59 MM
- ROCE(HY) Highest at 25.86%
- DEBT-EQUITY RATIO (HY) Lowest at -6.21 %
5
With ROCE of 30.33%, it has a attractive valuation with a 8.90 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.69%, its profits have risen by 31.5% ; the PEG ratio of the company is 1.2
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to ResMed, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is ResMed, Inc. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
ResMed, Inc.
5.06%
0.72
26.87%
S&P 500
20.12%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.79%
EBIT Growth (5y)
15.75%
EBIT to Interest (avg)
41.25
Debt to EBITDA (avg)
0.50
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.80
Tax Ratio
16.74%
Dividend Payout Ratio
22.30%
Pledged Shares
0
Institutional Holding
66.81%
ROCE (avg)
25.79%
ROE (avg)
21.53%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
8.54
EV to EBIT
29.89
EV to EBITDA
26.23
EV to Capital Employed
9.27
EV to Sales
9.80
PEG Ratio
1.21
Dividend Yield
2.53%
ROCE (Latest)
30.99%
ROE (Latest)
23.36%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1,914.49 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -9.15 %
DIVIDEND PER SHARE(HY)
Highest at USD 5.26
PRE-TAX PROFIT(Q)
Highest at USD 505.25 MM
RAW MATERIAL COST(Y)
Fallen by -5.62% (YoY
CASH AND EQV(HY)
Highest at USD 2,818.26 MM
NET SALES(Q)
Highest at USD 1,422.81 MM
OPERATING PROFIT(Q)
Highest at USD 562.62 MM
OPERATING PROFIT MARGIN(Q)
Highest at 39.54 %
NET PROFIT(Q)
Highest at USD 399.79 MM
EPS(Q)
Highest at USD 2.68
-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.26 times
DIVIDEND PAYOUT RATIO(Y)
Lowest at 22.37%
Here's what is working for ResMed, Inc.
Operating Cash Flow
Highest at USD 1,914.49 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
Highest at USD 505.25 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Debt-Equity Ratio
Lowest at -9.15 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Dividend per share
Highest at USD 5.26 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Sales
Highest at USD 1,422.81 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 562.62 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 39.54 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
Highest at USD 399.79 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 2.68
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 2,818.26 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -5.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ResMed, Inc.
Debtors Turnover Ratio
Lowest at 5.26 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Dividend Payout Ratio
Lowest at 22.37%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
